Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2179 studies found for:    Open Studies | "Hematologic Diseases"
Show Display Options
Rank Status Study
21 Unknown  Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell Transplantation
Condition: Hematologic Diseases
Intervention: Drug: Everolimus and mycophenolate sodium
22 Unknown  Intra Bone Marrow Injection Of Unrelated Cord Blood Cells
Condition: Hematologic Diseases
Intervention: Procedure: Intrabone Marrow Injection
23 Recruiting Bone Marrow Grafting for Leukemia and Lymphoma
Conditions: Leukemia;   Lymphoma;   Hematologic Diseases
Intervention: Procedure: collection and storage of tissue samples for research
24 Recruiting Natural History of Sickle Cell Disease and Other Hemolytic Disorders
Conditions: Hemoglobin SC Disease;   Hematologic Diseases;   Sickle Cell Anemia;   Hemolytic Anemia
25 Recruiting Prospective and Retrospective Cohort Study to Find New Prognostic Factors and Therapeutic Targets in Patients With Newly Diagnosed or Relapsed Malignant Hematologic Disorder Excluding Acute Leukemia
Condition: Malignant Hematologic Disorder
Intervention: Other: No intervention
26 Recruiting Investigation of the Genetics of Hematologic Diseases
Conditions: Bone Marrow Failure Syndromes;   Erythrocyte Disorder;   Leukocyte Disorder;   Hemostasis;   Blood Coagulation Disorder;   Sickle Cell Disease;   Dyskeratosis Congenita;   Diamond-Blackfan Anemia;   Congenital Thrombocytopenia;   Severe Congenital Neutropenia;   Fanconi Anemia
27 Recruiting The Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic Diseases
Condition: Chronic Lymphoid Leukemia
Interventions: Drug: Cholecalciferol;   Drug: oleum neutralicum
28 Recruiting Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases
Conditions: Acute Leukemias;   Burkitt's Lymphoma;   Chronic Myelogenous Leukemia
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation;   Biological: Haploidentical stem cell transplant
29 Recruiting Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident
Condition: Leukemia
30 Recruiting Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders
Conditions: Hematologic Disorders;   Oncologic Disorders;   Rheumatologic Disorders
Intervention: Drug: Rituximab
31 Recruiting Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia
Conditions: Hematological Diseases;   Thrombocytopenia
Interventions: Biological: MPs;   Drug: thrombopoietin (TPO) and interleukin-11
32 Recruiting A Study to Evaluate Long-term Safety in Subjects With Solid Tumors and Hematological Disorders.
Conditions: Hematologic Neoplasm;   Neoplasms
Intervention: Drug: CC-486
33 Recruiting Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease
Conditions: Acute Biphenotypic Leukemia;   Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome;   Acute Myeloid Leukemia in Remission;   Adult Acute Lymphoblastic Leukemia in Complete Remission;   Aggressive Non-Hodgkin Lymphoma;   Burkitt Lymphoma;   Childhood Acute Lymphoblastic Leukemia in Complete Remission;   Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Lymphoblastic Lymphoma;   Mantle Cell Lymphoma;   Myelofibrosis;   Pancytopenia;   Plasma Cell Myeloma;   Prolymphocytic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Chronic Lymphocytic Leukemia;   Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Recurrent Follicular Lymphoma;   Recurrent Lymphoplasmacytic Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Small Lymphocytic Lymphoma;   Refractory Anemia With Excess Blasts
Interventions: Drug: Cyclophosphamide;   Drug: Cyclosporine;   Procedure: Double-Unit Umbilical Cord Blood Transplantation;   Drug: Fludarabine Phosphate;   Other: Laboratory Biomarker Analysis;   Drug: Mycophenolate Mofetil;   Radiation: Total-Body Irradiation;   Procedure: Umbilical Cord Blood Transplantation
34 Recruiting Diamond Blackfan Anemia Registry (DBAR)
Conditions: Anemia;   Blood Disease
35 Not yet recruiting Clinical Performance of InRhythm PT/INR System in a Professional Use Setting
Condition: Blood Dyscrasia
Interventions: Procedure: SOC fingerstick;   Procedure: Venous blood draw
36 Recruiting Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2
Condition: Blood Disorders
Interventions: Other: Patient-Centered Medical Home (PCMH);   Other: Standard Care
37 Recruiting Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection
Conditions: Leukemia;   Lymphoma;   Blood Disorders;   Solid Tumors
Intervention: Drug: Ethanol lock therapy (ELT)
38 Not yet recruiting Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis/Treatment
Conditions: Cancer;   Hematologic Disorder;   Rheumatologic Disorder;   Infertility
Intervention: Procedure: Ovarian Cryopreservation
39 Recruiting URMC Related Haplo-identical Donor BMT
Conditions: Hematological Disease;   Immune Deficiencies;   Solid Tumors;   Myelofibrosis;   Multiple Myeloma;   Lymphoma
Interventions: Radiation: Total Body Irradiation 1200 cGy;   Drug: Fludarabine;   Drug: Pre-Stem Cell Infusion Cyclophosphamide;   Drug: Pre-Stem Cell Infusion Mesna;   Drug: Busulfan;   Drug: Melphalan;   Procedure: Stem Cell Infusion;   Drug: Post-Stem Cell Infusion Cyclophosphamide;   Drug: Post-Stem Cell Infusion Mesna
40 Recruiting Catheter Resistance Monitoring to Predict Catheter-Associated Adverse Events in Children and Adolescents
Conditions: Cancer;   Hematologic Disorders
Intervention: Other: Catheter Resistance Monitoring

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years